Key statistics
On Monday, Catalyst Pharmaceuticals Inc (CN2:DUS) closed at 19.64, 21.65% above the 52 week low of 16.15 set on Sep 26, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 19.11 |
|---|---|
| High | 19.64 |
| Low | 19.11 |
| Bid | 20.34 |
| Offer | 20.58 |
| Previous close | 20.82 |
| Average volume | 30.00 |
|---|---|
| Shares outstanding | 122.12m |
| Free float | 114.24m |
| P/E (TTM) | 13.70 |
| Market cap | 2.82bn USD |
| EPS (TTM) | 1.68 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 18:31 GMT.
More ▼
Announcements
- Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
- Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
- Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
- Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
- The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
- Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
- Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
- Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
- Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
More ▼
